Tartaric Acid
Medchemexpress LLC ENMD-2076 | 934353-76-1 | 99.99% | 375.47 | 50 MG
ENMD-2076 is a multi-targeted kinase inhibitor with IC50s of 1.86, 14, 58.2, 15.9, 92.7, 70.8, 56.4 nM for Aurora A, Flt3, KDR/VEGFR2, Flt4/VEGFR3, FGFR1, FGFR2, Src, PDGFRα, respectively. It is for research use only and not sold to patients.
- Multi-targeted kinase inhibitor
- Orally active
- Antiangiogenic and antiproliferative mechanisms of action
Aobchem (R R)-Tartaric acid N N N N -tetramethyldiamide | ≥97% | CAS 26549-65-5 | C8H16N2O4R2 | 100g
(R R)-Tartaric acid N N N N -tetramethyldiamide | ≥97% | CAS 26549-65-5 | C8H16N2O4R2 | 100g
Bioworld L-(+)-Tartaric Acid, 10% (w/v), 500 mL
L-(+)-Tartaric Acid Solution 10% (w/v) in biotechnology grade water.Appearance: LiquidBoiling Point : 399.3°CDensity : ~1.9 g/cm3 (Predicted)Melting Point: 170-172 °C(lit.)RTECS Number: WW7875000
Medchemexpress LLC Tartaric acid disodium dihydrate | 6106-24-7 | 98.0% | 25 G
Tartaric acid disodium dihydrate (L-(+)-tartaric acid) is an orally active weak organic acid isolated from grapes. It has vasodilatory and antihypertensive effects. It can be used as flavorings and antioxidants in various foods and beverages, as well as in laser frequency doubling and optical limiting applications.
- Orally active weak organic acid.
- Isolated from grapes.
- Exhibits vasodilatory and antihypertensive effects.
- Can be used as flavorings and antioxidants in foods and beverages.
- Applicable in laser frequency doubling and optical limiting.
Medchemexpress LLC ENMD-2076 Tartrate | 1453868-32-0 | 99.7% | 525.56 | 10 MG
ENMD-2076 Tartrate is a multi-targeted kinase inhibitor with IC50s of 1.86, 14, 58.2, 15.9, 92.7, 70.8, 56.4 nM for Aurora A, Flt3, KDR/VEGFR2, Flt4/VEGFR3, FGFR1, FGFR2, Src, PDGFRα, respectively. It is for research use only and not sold to patients.
- Acts as a multi-targeted kinase inhibitor
- Inhibits Aurora A, Flt3, KDR/VEGFR2, Flt4/VEGFR3, FGFR1, FGFR2, Src, and PDGFRα
- Shows selective inhibition of Aurora A over Aurora B
- Inhibits human umbilical vein endothelial cell (HUVEC) growth
- Blocks cellular Flt3 ligand (FL)-induced Flt3 autophosphorylation
- Prevents stem cell factor (SCF)-induced Kit autophosphorylation
- Inhibits VEGFR2/KDR autophosphorylation
- Demonstrates dose-dependent inhibition of tumor growth or tumor regression in vivo
- Exhibits good tolerance in daily doses during in vivo studies
Apexbio Technology LLC ENMD-2076 934353-76-1 5mg
ENMD-2076 (CAS 934353-76-1) is a selective inhibitor of Aurora A kinase (IC50 14 nM) and FLT3 (IC50 1 86 nM) with additional inhibitory activity against multiple tyrosine kinases implicated in angiogenesis and cell proliferation including RET FLT4/VEGFR3 SRC CSF1R NTRK1 FGFR1/2 VEGFR2/KDR LCK and PDGFR (IC50 1 86 120 nM) ENMD-2076 disrupts cell cycle progression by arresting cells in the G2/M phase through inhibition of Aurora kinases suppresses the PI3K/AKT signaling pathway and demonstrates cytotoxic effects in hematologic malignancy and solid tumor cell lines (in vitro IC50 25 700 nM) In vivo it reduces tumor growth and angiogenesis in xenograft models supporting its use in cancer research and antiangiogenic studies
![Alkali Scientific L (+) Tartaric Acid [(2R, 3R) (+) Tartaric acid/ L Threaric acid], 5 Kg](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000660100.jpg-250.jpg)
Alkali Scientific L (+) Tartaric Acid [(2R, 3R) (+) Tartaric acid/ L Threaric acid], 5 Kg
L (+) Tartaric Acid, ACS Grade, is a high-purity organic acid available in a 5 kg quantity. This chiral compound is essential for laboratory applications involving asymmetric synthesis and the production of optically active molecules. L (+) Tartaric acid is commonly used in the pharmaceutical and chemical industries for creating enantiomerically pure compounds, and it is an important reagent in biochemistry, organic chemistry, and analytical chemistry. This tartaric acid grade is ideal for use in optical isomer studies and in the development of various products, ensuring high purity and reliable results in laboratory experiments.
Selleck Chemical LLC ENMD-2076 S1181-10mM/1mL
ENMD-2076 has selective activity against Aurora A and Flt3 with IC50 of 14 nM and 1 86 nM 25-fold selective for Aurora A than over Aurora B and less potent to RET SRC NTRK1/TRKA CSF1R/FMS VEGFR2/KDR FGFR and PDGFR ENMD-2076 inhibits the growth of a wide range of human solid tumor and hematopoietic cancer cell lines with IC50 from 0 025 to 0 7 M which induces apoptosis and G2/M phase arrest Phase 2
Apexbio Technology LLC ENMD-2076 934353-76-1 200mg
ENMD-2076 (CAS 934353-76-1) is a selective inhibitor of Aurora A kinase (IC50 14 nM) and FLT3 (IC50 1 86 nM) with additional inhibitory activity against multiple tyrosine kinases implicated in angiogenesis and cell proliferation including RET FLT4/VEGFR3 SRC CSF1R NTRK1 FGFR1/2 VEGFR2/KDR LCK and PDGFR (IC50 1 86 120 nM) ENMD-2076 disrupts cell cycle progression by arresting cells in the G2/M phase through inhibition of Aurora kinases suppresses the PI3K/AKT signaling pathway and demonstrates cytotoxic effects in hematologic malignancy and solid tumor cell lines (in vitro IC50 25 700 nM) In vivo it reduces tumor growth and angiogenesis in xenograft models supporting its use in cancer research and antiangiogenic studies
Medchemexpress LLC Fosphenytoin disodium | 92134-98-0 | MFCD20527322 | >98.0% | 406.24 g/mol | C16H13N2Na2O6P | 10 MG
Fosphenytoin disodium is the water-soluble disodium salt prodrug of phenytoin supplied for research use only. It functions as an anticonvulsant by reducing repetitive neuronal firing through blockade of voltage-gated sodium channels and is used as a reference compound in pharmacology and analytical studies.
- water-soluble prodrug of phenytoin suitable for biochemical and pharmacological assays.
- high purity (greater than 98%) for reliable experimental results.
- molecular formula C16H13N2Na2O6P and molecular weight approximately 406.24 g/mol.
- provided as a small research pack for analytical standards and in vitro testing.
- intended for research use only; not for human or veterinary use.
eMolecules 2743-38-6 | Dibenzoyl-l-tartaric acid | Combi-Blocks358.302 | C18H14O8 | 97.000 | OC(=O)[C@H](OC(=O)c1ccccc1)[C@@H](OC(=O)c1ccccc1)C(O)=O | 25g | 290705434
Dibenzoyl-l-tartaric acid | Combi-Blocks | 2743-38-6358.302 | C18H14O8 | 97.000 | OC(=O)[C@H](OC(=O)c1ccccc1)[C@@H](OC(=O)c1ccccc1)C(O)=O | 25g | 290705434
Medchemexpress LLC Prednisolone disodium phosphate | 125-02-0 | 99.5% | 1 ML
Prednisolone disodium phosphate is a synthetic glucocorticoid with anti-inflammatory and immunomodulating properties. It can be rapidly and completely hydrolyzed to Prednisolone in the plasma.
- Synthetic glucocorticoid
- Exhibits anti-inflammatory properties
- Possesses immunomodulating properties
- Rapidly hydrolyzed to Prednisolone in plasma
- Soluble in water (50 mg/mL) and PBS (100 mg/mL)
- Available in solid and solution forms
Medchemexpress LLC ENMD-2076 Tartrate | 1453868-32-0 | 99.66% | 525.56 | 50 MG
ENMD-2076 Tartrate is a multi-targeted kinase inhibitor primarily targeting Aurora A, Flt3, and VEGFR2. It is intended for research use only and not for patient applications. This compound is known for its inhibitory effects on various kinases, contributing to its potential in anti-proliferative and anti-angiogenic research.
- Exhibits potent inhibition of Aurora A, Flt3, KDR/VEGFR2, Flt4/VEGFR3, FGFR1, FGFR2, Src, and PDGFRα.
- Induces G2-M-phase arrest and apoptosis in U937 cells.
- Inhibits Flt3 and Kit autophosphorylation.
- Shows dose-dependent inhibition of tumor growth in vivo.
Chem-Impex International, Inc. (-)-Dibenzoyl-L-tartaric acid | MFCD00003074 | 1KG
(-)-Dibenzoyl-L-tartaric acid, MFCD00003074, 1KG